MOLECULAR SCREENING OF JAPANESE PATIENTS WITH GAUCHER DISEASE - PHENOTYPIC VARIABILITY IN THE SAME GENOTYPES

被引:14
作者
KAWAME, H [1 ]
MAEKAWA, K [1 ]
ETO, Y [1 ]
机构
[1] JIKEI UNIV SCH MED,DEPT PEDIAT,TOKYO 105,JAPAN
关键词
GAUCHER DISEASE; GLUCOCEREBROSIDASE (GC); MUTATION ANALYSIS; PHENOTYPE GENOTYPE CORRELATIONS;
D O I
10.1002/humu.1380020507
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Gaucher disease is the most prevalent sphingolipidosis, characterized by genetic deficiency of lysosomal hydrolase glucocerebrosidase, and is inherited in an autosomal recessive manner. To characterize the molecular basis of Gaucher disease in Japan, we analyzed for the presence of the two known mutations (1448C and 754A) in the glucocerebrosidase gene of 15 patients (14 families) with Gaucher disease by selective amplification and restriction endonuclease analysis. We found that the 1448C and 754A mutations occurred in all three clinical subtypes of Japanese Gaucher disease patients. The 1448C mutation was found on 12 (40%) out of 30 chromosomes (44% allele frequency in nonneuronopathic form, and 33% in neuronopathic forms), while homozygosity for this mutation was only found in two nonneuronopathic patients (age of 1 year 6 months and 7 years). We detected the 754A mutation on 6 (20%) out of 30 chromosomes. No patient was homozygous for 754A mutation. Furthermore, we identified four patients who were compound hetrozygote for 754A and 1448C. One of these was a type 3 Gaucher patient, but the other three patients were free from central nervous system manifestations at the time of observation. These results indicate that phenotypic presentation of Gaucher disease including the presence of nervous manifestation, progression, and severity of disease, may be affected by other genetic, environmental, or developmental factors, as well as the glucocerebrosidase genotype. (C) 1993 Wiley-Liss, Inc.
引用
收藏
页码:362 / 367
页数:6
相关论文
共 30 条
[1]  
Barranger J. A., 1989, METABOLIC BASIS INHE, P1677
[2]   POLYMORPHISMS IN THE HUMAN GLUCOCEREBROSIDASE GENE [J].
BEUTLER, E ;
WEST, C ;
GELBART, T .
GENOMICS, 1992, 12 (04) :795-800
[3]  
BEUTLER E, 1991, NEW ENGL J MED, V325, P1354
[4]   GAUCHER DISEASE - NEW MOLECULAR APPROACHES TO DIAGNOSIS AND TREATMENT [J].
BEUTLER, E .
SCIENCE, 1992, 256 (5058) :794-799
[5]   IDENTIFICATION OF THE 2ND COMMON JEWISH GAUCHER DISEASE MUTATION MAKES POSSIBLE POPULATION-BASED SCREENING FOR THE HETEROZYGOUS STATE [J].
BEUTLER, E ;
GELBART, T ;
KUHL, W ;
SORGE, J ;
WEST, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) :10544-10547
[6]  
BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P211
[7]  
DAHL N, 1990, AM J HUM GENET, V47, P275
[8]  
FIRON N, 1990, AM J HUM GENET, V46, P527
[9]   ISOLATION OF CDNA CLONES FOR HUMAN BETA-GLUCOCEREBROSIDASE USING THE LAMBDA-GT11 EXPRESSION SYSTEM [J].
GINNS, EI ;
CHOUDARY, PV ;
MARTIN, BM ;
WINFIELD, S ;
STUBBLEFIELD, B ;
MAYOR, J ;
MERKLELEHMAN, D ;
MURRAY, GJ ;
BOWERS, LA ;
BARRANGER, JA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 123 (02) :574-580
[10]   A CASE OF NONNEUROLOGIC GAUCHERS-DISEASE THAT BIOCHEMICALLY RESEMBLES THE NEUROLOGIC TYPES [J].
GLEW, RH ;
GOPALAN, V ;
HUBBELL, CA ;
BEUTLER, E ;
GEIL, JD ;
LEE, RE .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1991, 50 (02) :108-117